Hepatic safety of leflunomide (LEF) in patients with rheumatoid arthritis: Results from the relief study

被引：0
|
作者：
Dougados, M
Larrey, DD
Solal-Celigny, R
Murray, GGD
Brin, SS
Smolen, JJ
机构：
[1] Univ Paris 05, Paris 14, France
[2] Hop St Eloi, Montpellier, France
[3] Ctr Jean Bernard, Le Mans, France
[4] Univ Edinburgh, Med Stat Unit, Edinburgh EH8 9YL, Midlothian, Scotland
[5] Lab Aventis, Paris, France
[6] Univ Vienna, Interne Abt, A-1010 Vienna, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of leflunomide (LEF) in patients rheumatoid arthritis who failed previous DMARDS therapy
    Ionescu, R
    Popescu, E
    Georgescu, L
    Predetean, D
    Balanescu, A
    Bojinca, V
    Dumitrescu, C
    Opris, D
    Belibou, C
    Popovici, H
    Cozos, A
    Parvu, M
    Sarchiz, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 407 - 407
  • [2] The safety and efficacy of leflunomide (LEF) in combination with infliximab (INF) in rheumatoid arthritis (RA).
    Hansen, KE
    Cush, J
    Singhal, A
    Cooley, DA
    Cohen, S
    Patel, SR
    Genovese, M
    Sundaramurthy, S
    Schiff, M
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S84 - S84
  • [3] Efficacy and safety of leflunomide (LEF) versus methotrexate (MTX) in the treatment of pediatric patients with juvenile rheumatoid arthritis
    Silverman, E
    Prieur, A
    Spiegel, L
    Jung, LK
    Saurenmann, RK
    Lahdenne, PO
    Szer, IS
    Simpson, K
    Stewart, J
    Strand, V
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 195 - 195
  • [4] Efficacy and safety of leflunomide (LEF) versus methotrexate (MTX) in the treatment of pediatric patients with juvenile rheumatoid arthritis (JRA).
    Silverman, E
    Spiegel, L
    Jung, LK
    Saurenmann, RK
    Lahdenne, P
    Szer, IS
    Strand, V
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3654 - 3654
  • [5] Efficacy of and predisposing factors for response to leflunomide (LEF) in patients with rheumatoid arthritis (RA)
    Dougados, M
    Antoine, C
    Brin, S
    Emery, P
    Lemmel, EM
    de la Serna, AR
    Zerbini, CAF
    Van Riel, P
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 : 105 - 105
  • [6] Five year follow-up: Efficacy and safety of leflunomide (LEF) in patients with active rheumatoid arthritis (RA).
    Kalden, J
    Schattenkirchner, M
    Sorensen, H
    Emery, P
    Deighton, C
    Rozman, B
    Breedveld, F
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S173 - S173
  • [7] The Efficacy and Safety of Leflunomide in Patients with Active Rheumatoid Arthritis
    Wiacek, Ryszard
    Kolossa, Katarzyna
    Jankowski, Tomasz
    Jeka, Slawomir
    Karmowski, Andrzej
    Karmowski, Mikolaj
    Gworys, Bohdan
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 21 (03): : 337 - 342
  • [8] Safety evaluation of leflunomide in rheumatoid arthritis
    Keen, Helen I.
    Conaghan, Philip G.
    Tett, Susan E.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 581 - 588
  • [9] An initial evaluation of the efficacy and safety of leflunomide (LEF) in children with polyarticular course juvenile rheumatoid arthritis (JRA).
    Silverman, E
    Spiegel, L
    Hawkins, D
    Petty, R
    Goldsmith, D
    Schanberg, L
    Duffy, C
    Howard, P
    Desai, K
    Strand, V
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S272 - S272
  • [10] Treatment of rheumatoid arthritis (RA) with leflunomide (LEF) in routine clinical practice
    Irvine, S. A.
    McGhee, D.
    Fraser, S. M.
    Morrison, E.
    [J]. RHEUMATOLOGY, 2001, 40 : 33 - 33
12345